These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21897269)

  • 21. Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.
    Lupe K; D'Souza DP; Kwon JS; Radwan JS; Harle IA; Hammond JA; Carey MS
    Gynecol Oncol; 2009 Jul; 114(1):94-8. PubMed ID: 19406459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma. A multi-institutional study.
    Mahdi H; Rose PG; Elshaikh MA; Munkarah A; Isrow D; Singh S; Waggoner S; Ali-Fehmi R; Morris RT; Harding J; DeBenardo R
    Gynecol Oncol; 2015 Mar; 136(3):529-33. PubMed ID: 25575483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single institution experience using sequential multi-modality adjuvant chemotherapy and radiation in the "sandwich" method for high risk endometrial carcinoma.
    Geller MA; Ivy J; Dusenbery KE; Ghebre R; Isaksson Vogel R; Argenta PA
    Gynecol Oncol; 2010 Jul; 118(1):19-23. PubMed ID: 20381136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes following surgery and adjuvant radiation in stage II endometrial adenocarcinoma.
    Cannon GM; Geye H; Terakedis BE; Kushner DM; Connor JP; Hartenbach EM; Bradley KA
    Gynecol Oncol; 2009 May; 113(2):176-80. PubMed ID: 19217147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Choosing the right adjuvant therapy for stage III-IVA endometrial cancer: A comparative analysis of chemoradiotherapy and chemotherapy.
    Kim HJ; Lee J; Lee KB; Sung K; Kim YB; Kim YS
    Gynecol Oncol; 2024 Mar; 182():39-44. PubMed ID: 38246045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach.
    Lupe K; Kwon J; D'Souza D; Gawlik C; Stitt L; Whiston F; Nascu P; Wong E; Carey MS
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):110-6. PubMed ID: 17084542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival.
    Boothe D; Orton A; Odei B; Stoddard G; Suneja G; Poppe MM; Werner TL; Gaffney DK
    Gynecol Oncol; 2016 Jun; 141(3):421-427. PubMed ID: 27005441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women.
    Macdonald OK; Sause WT; Lee RJ; Lee CM; Dodson MK; Zempolich K; Gaffney DK
    Gynecol Oncol; 2006 Nov; 103(2):661-6. PubMed ID: 16797682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved Outcome of High-Grade, Early 1-Stage Endometrioid Endometrial Carcinoma With Adjuvant Chemotherapy and Radiotherapy: Comparison of 2 Treatment Strategies.
    Reynaers EA; Jutzi L; Ezendam NP; Kwon JS; Pijnenborg JM
    Int J Gynecol Cancer; 2017 Mar; 27(3):467-472. PubMed ID: 28129237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
    Kuku S; Williams M; McCormack M
    Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The outcome and efficacy of adjuvant chemotherapy alone in patients with stage IIIA endometrial carcinoma with solitary adnexal involvement: a retrospective single-institution study.
    Lan C; Huang X; Huang Y; Xi S; Huang H; Feng Y; Liu J
    Gynecol Oncol; 2014 Dec; 135(3):446-50. PubMed ID: 25158035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of nodal recurrences of endometrial cancer with IMRT.
    Ho JC; Allen PK; Jhingran A; Westin SN; Lu KH; Eifel PJ; Klopp AH
    Gynecol Oncol; 2015 Oct; 139(1):40-6. PubMed ID: 26193429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
    Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
    Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy.
    Chang-Halpenny CN; Natarajan S; Hwang-Graziano J
    Gynecol Oncol; 2013 Dec; 131(3):598-603. PubMed ID: 24135679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.
    Simpkins F; Papadia A; Kunos C; Michener C; Frasure H; AbuShahin F; Mariani A; Bakkum-Gamez JN; Landrum L; Moore K; Thomas SG; Windhorn A; Rose PG
    Int J Gynecol Cancer; 2013 Jan; 23(1):98-104. PubMed ID: 23221731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.
    Greven K; Winter K; Underhill K; Fontenesci J; Cooper J; Burke T;
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):168-73. PubMed ID: 15093913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative adjuvant chemotherapy with cisplatin, cyclophosphamide, and anthracycline (doxorubicin, epirubicin, pirarubicin) for endometrial cancer.
    Yahata H; Hirakawa T; Fujita T; Ariyoshi K; Sonoda K; Amada S; Kobayashi H; Nakano H
    Int J Clin Oncol; 2004 Aug; 9(4):317-21. PubMed ID: 15375709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.